Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Italian Journal of Dermatology and Venereology
|
October 21, 2020
A case of spontaneous regression of metastatic skin undifferentiated carcinoma
Mauro Mazzeo, Dioniosio Silvaggio, Flavia Lozzi, et al.
Archives of Dermatology
|
February 22, 2012
Constitutional intraepidermal ascent of melanocytes: a potential pitfall in the diagnosis of melanocytic lesions
Katrin Kerl, Werner Kempf, Jivko Kamarashev, et al.
Drug Development Research
|
November 11, 2014
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations
Barbara Marinari, Elisabetta Botti, Mauro Bavetta, et al.
Dermatologic Therapy
|
October 14, 2019
Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities
Giulia Spallone, Pietro Sollena, Alessandra Ventura, et al.
Dermatologic Therapy
|
July 27, 2020
Efficacy of Vismodegib in pigmented basal cell carcinoma: Appearances are deceiving
Cosimo Di Raimondo, Mauro Mazzeo, Monia Di Prete, et al.
Frontiers in Molecular Biosciences
|
June 18, 2020
Stem-Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients
Maria Cristina Rapanotti, Elena Campione, Tara Mayte Suarez Viguria, et al.
The Australasian Journal of Dermatology
|
October 11, 2020
Cutaneous mastocytosis: A dermatological perspective
Cosimo Di Raimondo, Ester Del Duca, Dionisio Silvaggio, et al.
International Journal of Dermatology
|
July 2, 2021
Baseline neutrophil/lymphocyte ratio (NLR) and red blood cell distribution width (RDW) correlate with advanced stages in cutaneous squamous cell carcinoma
Cosimo Di Raimondo, Raffaele Dante Caposiena Caro, Diana Spallone, et al.
Dermatology Reports
|
February 18, 2025
Real-world experience with vismodegib and sonidegib in advanced basal cell carcinoma: a multicenter Italian study
Mario Valenti, Sara Di Giulio, Andrea Carugno, et al.
Chemotherapy
|
August 11, 2020
High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature
Elena Campione, Monia Di Prete, Flavia Lozzi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Italian Journal of Dermatology and Venereology
|
October 21, 2020
A case of spontaneous regression of metastatic skin undifferentiated carcinoma
Mauro Mazzeo, Dioniosio Silvaggio, Flavia Lozzi, et al.
Archives of Dermatology
|
February 22, 2012
Constitutional intraepidermal ascent of melanocytes: a potential pitfall in the diagnosis of melanocytic lesions
Katrin Kerl, Werner Kempf, Jivko Kamarashev, et al.
Drug Development Research
|
November 11, 2014
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations
Barbara Marinari, Elisabetta Botti, Mauro Bavetta, et al.
Dermatologic Therapy
|
October 14, 2019
Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities
Giulia Spallone, Pietro Sollena, Alessandra Ventura, et al.
Dermatologic Therapy
|
July 27, 2020
Efficacy of Vismodegib in pigmented basal cell carcinoma: Appearances are deceiving
Cosimo Di Raimondo, Mauro Mazzeo, Monia Di Prete, et al.
Frontiers in Molecular Biosciences
|
June 18, 2020
Stem-Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients
Maria Cristina Rapanotti, Elena Campione, Tara Mayte Suarez Viguria, et al.
The Australasian Journal of Dermatology
|
October 11, 2020
Cutaneous mastocytosis: A dermatological perspective
Cosimo Di Raimondo, Ester Del Duca, Dionisio Silvaggio, et al.
International Journal of Dermatology
|
July 2, 2021
Baseline neutrophil/lymphocyte ratio (NLR) and red blood cell distribution width (RDW) correlate with advanced stages in cutaneous squamous cell carcinoma
Cosimo Di Raimondo, Raffaele Dante Caposiena Caro, Diana Spallone, et al.
Dermatology Reports
|
February 18, 2025
Real-world experience with vismodegib and sonidegib in advanced basal cell carcinoma: a multicenter Italian study
Mario Valenti, Sara Di Giulio, Andrea Carugno, et al.
Chemotherapy
|
August 11, 2020
High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature
Elena Campione, Monia Di Prete, Flavia Lozzi, et al.
Page
of 3